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BMP7-induced-Pten inhibits Akt and prevents renal fibrosis

Introduction:
Bone morphogenetic protein -7 (BMP-7 , or osteogenic protein (OP)-1) is a 35kDa member of the transforming growth factor beta (TGFβ) family of secreted extracellular proteins. In addition to its role in regulating bone and cartilage formation, BMP-7 is essential for renal morphogenesis, stimulating condensation of the metanephric mesenchyme around the ureteric bud, leading to the formation of collecting duct epithelia through promotion of mesenchymal to epithelial transition (MET).
1-4 BMP-7 null mice die soon after birth due to renal hypoplasia associated with reduced ureteric bud branching, loss of metanephric mesenchyme, cessation of nephrogenesis and a marked reduction of glomerular density. 2, 5 BMP-7 expression is retained in adult kidneys and is thought to be critical for maintaining tubular epithelial integrity. [6] [7] [8] [9] [10] [11] [12] [13] During renal disease, interaction of BMP-7
with distinct serine / threonine kinase receptors is prevented by binding to endogenously generated antagonists such as gremlin, noggin and USAG-1 (Uterine sensitization-associated gene -1, also referred to as Sclerostin domain containing -1 , Sostdc1), 13 facilitating damage to the tubular epithelium. Several studies have reported that introduction of exogenous recombinant BMP-7 or reactivation of endogenous BMP-7 signaling through peptide mediated receptor activation can prevent progression of renal disease. 7, 8, 10, [14] [15] [16] [17] BMP-7 is reno-protective in acute and chronic renal injury models (reviewed in 18 ) including ischemia reperfusion injury (IRI), 7, 14 unilateral ureteral obstruction (UUO), 8, [19] [20] [21] 5/6 nephrectomy, 3, 22 lupus nephritis, nephrotoxic serum nephritis (NTN), Collagen type 4α3-null 'Alport' mice, 23 and STZinduced diabetic nephropathy. 24, 25 BMP-7 is efficacious in other fibrotic diseases including cardiac, 26 liver, 27, 28 corneal, 29 and silica induced pulmonary fibrosis. 30 Preservation of renal function, normalisation of serum creatinine, reduction of extracellular matrix accumulation, and reduction in pro-inflammatory mediators have been demonstrated. 7, 8, 14, 19, 23, 31 However, the molecular mechanisms involved in this protection have not been fully defined. In this report, we describe the effect of BMP-7 on key signaling pathways underlying fibrogenesis.
TGFβ 1 is the prototypic pro-sclerotic cytokine which is aberrantly up-regulated during fibrotic disease. It is responsible for the induction and accumulation of interstitial matrix, which is considered the pathological hallmark of all kidney injuries regardless of the aetiology. 16 and Alk2 in cartilage. 10, 31 The importance of Alk3 in mediating the protective effects of renal BMP-7 signaling was borne out by the enhanced pro-fibrotic effects of TGFβ 1 observed upon deletion of Alk3 in the tubular epithelium. 16 The principle drivers of injury in UUO include TGFβ 1 and hypoxia. 49 In this report, we describe the effect of BMP-7 on hypoxia-and TGFβ 1 -induced signaling pathways in the unilateral ureteral obstruction (UUO) model of renal fibrosis. We report that BMP-7 inhibits activation of PI3K signaling via Akt in addition to inhibition of SMAD3 in vivo. We demonstrate that BMP-7 specifically inhibits TGFβ 1 -and hypoxia-induced PI3K activity in renal collecting duct and tubular epithelial cells via upregulation of the PI3K inhibitor phosphatase and tensin homolog (PTEN).
Results: BMP-7 preserves pSMAD1/5/8 activity in fibrotic kidneys
Phosphorylation of SMAD1/5/8 was analysed in contralateral (CTL) and obstructed (UUO) kidneys to determine whether exogenous recombinant human BMP-7 (rhBMP-7) administered via i.p. injection could activate BMP-7 signaling in renal tissue. In vehicle treated animals, pSMAD1/5/8 was detected in the contralateral kidney (veh-CTL) but lost during development of fibrosis in the corresponding obstructed kidneys (veh-UUO) (P<0.001, Figure 1A and Supplemental Table 1 ). In contrast, in animals treated with rhBMP-7, pSMAD1/5/8 was detected in the obstructed kidneys (BMP-7-UUO)
suggesting maintenance of BMP-7 responsive pathways, confirming functional activity of exogenously applied rhBMP-7 in the kidney ( Figure 1A ).
As a further readout for activation of BMP-7 pathways, expression of the BMP-7-target gene Id-1 was analysed. In vehicle-UUO kidneys, Id-1 mRNA was significantly down-regulated (P<0.01, Figure   1A and Supplemental Figure 1B ). Despite reducing collagen accumulation, BMP-7 had no effect on UUO-induced α-SMA protein (P<0.05 in veh-UUO and BMP-7 UUO compared to respective contralateral kidneys, Figure 2A&B ) or mRNA expression (P<0.001, in veh-UUO and BMP-7-UUO compared to respective contralateral kidneys, Figure 2C and Supplemental Table 1 ). Additionally, BMP-7 had no effect on Fsp-1 mRNA expression as a marker of interstitial injury in fibrotic kidneys (P<0.001 in veh-UUO and BMP-7-UUO compared to respective contralateral kidneys, Figure 2C and Supplemental Table 1 ). 
BMP-7 reduces renal fibrosis in vivo via reduced Collagen I and III and enhanced Collagen IV
To determine the specific collagen types that were altered by BMP-7 treatment, Collagen Iα1, IIIα1, and IVα1 proteins were assessed by immunohistochemistry ( Figure 3A and B). Collagen Iα1 was significantly increased in veh-UUO kidneys (P<0.01) whereas there was no significant increase observed in BMP-7-UUO kidneys (P>0.05, Figure 3A and B and Supplemental Table 1 ). Similarly, Col
Iα1 mRNA was significantly increased in veh-UUO compared to veh-CTL kidneys (P<0.001, Figure 3C ).
While there was a significant increase in Col Iα1 mRNA between BMP-7-CTL and BMP-7-UUO kidneys (P<0.001, Figure 2C ), Col Iα1 gene expression was significantly reduced in both contralateral and obstructed kidneys of BMP-7-treated animals compared with vehicle treated animals (P<0.001).
Collagen IIIα1 protein was significantly increased in BMP-7-UUO kidneys compared to BMP-7-CTL kidneys (P<0.01), and unlike Collagen Iα1, there was no significant difference in the quantity of Collagen IIIα1 protein between veh-UUO kidneys and BMP-7-UUO (P>0.05, Figure 3A & B and
Supplemental Table 1 ). However, induction of Collagen IIIα1 mRNA in UUO kidneys was significantly impaired (P=0.002) in animals treated with BMP-7 (P<0.001in veh-UUO and BMP-7 UUO versus respective CTL kidneys, Figure 3C ).
Collagen IVα1 protein was not significantly increased in UUO kidneys compared with CTL kidneys of either group (P>0.05, Figure 2A & B and Supplemental Table 1 ). However, Col IVα1 mRNA was significantly increased in BMP-7-UUO kidneys compared with vehicle-UUO kidneys (P<0.001, Figure   3C ). 
BMP-7 inhibits phosphorylation of SMAD3 but not SMAD2 in vivo
To determine the effects of BMP-7 on TGFβ 1 -mediated signaling pathways in vivo, activation of canonical signaling, via SMAD2 and SMAD3 ( Figure 4 and Supplemental Table 1 ), and non-canonical signaling, via ERK, p38 and Akt, was analysed ( Figure 5 and Supplemental Table 1 ). While BMP-7 had no effect on the activation and phosphorylation of SMAD2 in UUO kidneys, phosphorylation of SMAD3 was completely ablated in both contralateral and UUO kidneys of BMP-7 treated animals (P<0.001, Figure 4 ). This is the first report of inhibition of SMAD3 by BMP-7 in whole kidneys in vivo and corroborates the reported BMP-7-inhibition of SMAD3 in mesangial cells in vitro. 
BMP-7 inhibits phosphorylation of Akt but not ERK or p38 MAPK in vivo
Renal fibrosis in vivo was associated with activation of PI3K signaling as determined by phosphorylation of Akt on Serine 473 and Threonine 308 . Activation of PI3K signaling was significantly impaired in BMP-7-UUO kidneys compared with vehicle-UUO kidneys (P<0.001, Figure 5A and Supplemental Table 1 ). To determine whether this inhibition had effects further downstream of Akt, the phosphorylation status of the Akt target GSK3β was investigated. UUO significantly increased the phosphorylation, and thus inactivation, of GSK3β (P<0.05 in vehicle kidneys) and this was significantly reduced in BMP-7 treated UUO kidneys (P<0.01, Figure 5A ).
In contrast, BMP-7 did not alter the activation status of ERK or p38, both of which were significantly up-regulated in response to UUO (pERK: P<0.001 in vehicle kidneys and P<0.01 in BMP-7 kidneys compared to respective contralateral kidneys, p38: P<0.01 in BMP7-UUO kidneys versus BMP7-CTL,
Figure 5B and Supplemental Table 1 ). Our findings suggest that the protective role of BMP-7 in vivo is mediated via inhibition of both SMAD3 and Akt signaling. To determine the effects of BMP-7 on TGFβ 1 -induced signaling in vitro, collecting duct epithelia (mIMCD) were co-stimulated with 100ng/ml BMP-7 and 5ng/ml TGFβ 1 . BMP-7 inhibited TGFβ 1 -induced phosphorylation of Akt at Ser 473 but not at Thr 308 (P<0. 05, Figure 6A and Supplemental Table 1 ). TGFβ 1 induced phopshorylation of GSK3β (P<0.05, Figure 6A ) and reduced E-cadherin protein (P<0.01, Figure 6A ), although BMP-7 did not alter the phosphorylation status of GSK3β it restored E-cadherin protein expression (P<0.05 versus TGFβ, Figure 6A ). BMP-7 had no effect on TGFβ 1 -induced phosphorylation of ERK and p38 ( Figure 6B ). Phosphatase and tensin homologue (PTEN) negatively regulates PI3K signaling by converting PIP 3 back to PIP 2 . 50 In UUO kidneys, gene expression of Pten was significantly reduced in response to UUO in vehicle treated animals (P<0.05, Figure 7A ) consistent with the observed phosphorylation of Akt ( Figure 5A ). However, the opposite was observed in UUO-kidneys from BMP-7-treated animals where Pten expression was significantly up-regulated compared to contralateral kidneys (P<0.05, Figure 7A ), consistent with the observed dephosphorylation of Akt in BMP-7-UUO kidneys ( Figure   5A ).
Similarly in collecting duct cells, BMP-7 induced expression of Pten (P<0.05, Figure 7B ). Interestingly, when collecting duct epithelia were co-stimulated with BMP-7 and TGFβ 1 expression of Pten was further amplified (P<0.05 versus individual treatments, Figure 7B ). This synergistic effect of BMP-7
and TGFβ 1 on Pten expression correlates with the reduction of Akt phosphorylation observed in the BMP-7-UUO kidneys ( Figure 5A ).
Figure 7: BMP-7 increases expression of Akt negative regulator Pten in vivo and in vitro.
Quantitative PCR analysis of Pten mRNA normalised to 18S expression in A contralateral (C) and obstructed (U) kidneys from vehicle-treated (Veh) and BMP-7-treated animals, n=5 for vehicle and BMP-7 groups, B collecting duct epithelial cells treated with vehicle (V), BMP-7 (B, 100ng/ml), TGFβ 1 (T, 5ng/ml), or combined BMP-7 and TGFβ 1 (BT). Treatments were performed in triplicate and the experiments repeated three times. Statistical analysis was determined by one-way ANOVA and Bonferroni's multiple comparison test, *P<0.05, **P<0.001.
Discussion:
A protective role for BMP-7 has been reported in a number of renal injury models however, the molecular mechanisms by which BMP-7 exerts this protection have focussed primarily in vitro on the effect of BMP-7 on TGFβ 1 -induced extracellular matrix (ECM) accumulation, 10, 51 and E-cadherin expression in cultured renal cells 11 , and genomic methylation. [52] [53] [54] [55] [56] [57] Here we describe specific effects of BMP-7 on TGFβ 1 -signaling and show in vivo and in vitro that BMP-7 not only inhibits activation of SMAD3 but also inhibits Akt resulting in loss of pro-fibrotic signals and protection from fibrogenesis.
Exogenous rhBMP-7 activated SMAD1/5/8 signaling within the obstructed kidney, maintaining the expression of the BMP-7 target gene Id1 (Figure 1 ). Gene expression of Bmp-7 was significantly down-regulated in response to injury in vehicle treated animals, similar to reports in human renal disease [58] [59] [60] , however rhBMP-7 induced a significant induction of Bmp-7 mRNA expression suggesting that BMP-7 can regulate its own expression in a positive feed forward loop ( Figure 1B ).
BMP-7 prevented the up-regulation of Usag1 expression observed in veh-UUO kidneys ( Figure 1B) suggesting that BMP-7 can regulate it's bioactivity by inhibiting expression of its antagonists.
Additionally, in BMP-7-CTL kidneys Grem1 expression was significantly up-regulated, perhaps in an attempt to regulate the bioactivity of exogenous BMP-7 under physiologic conditions. This induction of Grem1 was not observed in BMP-7-UUO kidneys suggesting the involvement of active BMP-7
under pathophysiologic conditions as a protective mechanism against fibrosis.
Remarkably, BMP-7 abrogated fibrosis and ECM deposition despite an inability to alter myofibroblast activation. Similar induction of α-SMA, the hallmark marker of the myofibroblast, was observed in fibrotic kidneys from both vehicle-and BMP7-treated animals suggesting that BMP-7 works downstream of myofibroblast activation to block ECM production ( Figure 2 ). Myofibroblast numbers are increased during renal fibrosis and they are considered to contribute to collagen and ECM production in fibrotic diseases. 61 Interestingly, Takeji et al reported that α-SMA null mice had significantly worse renal disease, in two separate in vivo models, than mice wild-type for α-SMA expression, concluding that myofibroblasts play a role in suppressing renal fibrosis. Given their findings, it is perhaps not surprising that the beneficial effects of BMP-7 require that myofibroblast activation and α-SMA expression remains intact. In contrast to the inhibitory effects of BMP-7 on SMAD3, BMP-7 had no effect on ERK and p38 MAPK signaling pathways in vivo or in cultured epithelia, consistent with the findings of Wang and
Hirschberg in mesangial cells. 43 However, BMP-7 significantly reduced phosphorylation of PI3K, Akt and GSK3β. In veh-UUO kidneys, both phosphorylated Akt-Ser 473 and -Thr 308 were increased, however both phosphorylation events were inhibited in the presence of BMP-7 ( Figure 5 ). In vitro, BMP-7 inhibited TGFβ 1 -induced phosphorylation of Akt-Ser 473 in collecting duct epithelial cells ( Figure 6 ) and hypoxia-induced phosphorylation of Akt-Ser 473 in proximal tubular epithelial cells (Supplemental Figure 1) . However, only the initial phosphorylation event at Ser 473 was successfully inhibited by BMP-7 whereas phopsho-Akt -Thr 308 was still detected in cultured cells in vitro. This may be due to increased secretion of endogenous TGFβ 1 or other cytokines that may overcome BMP-7's ability to inhibit PI3K signaling in vitro.
Under physiologic conditions, active GSK3β phosphorylates β-catenin causing its ubiquitination and degradation. In response to renal injury in veh-UUO kidneys ( Figure 5 ) or to TGFβ 1 (Figure 6 ), phosphorylation and inactivation of GSK3β results in stabilisation and nuclear translocation of β-catenin inducing the expression of its target gene Snai1. 65, 66 Snail is an E-cadherin E-box transcriptional repressor which decreases E-cadherin protein as part of the epithelial injury process. 67 Inactivation of GSK3β, observed during renal injury, inhibits interaction between GSK3β and Snail, resulting in nuclear translocation of Snail and repression of E-cadherin transcription 65, 66 . including UUO, aristocholic acid induced nephropathy (AAN), and streptozotocin-mediated injury. 68 We now report that BMP-7 can prevent the loss of PTEN during UUO-induced fibrosis ensuring that activation of Akt does not occur ( Figure 7 ).
Akt has been implicated in renal fibrogenesis previously, however this is the first report of BMP-7 as (Figures 4-6) , and that these effects are mediated by up-regulation of PTEN ( Figure 7 ). In addition to inhibition of SMAD3, BMP-7 promoted activation of SMAD2-mediated signaling (Supplemental Figure 1) , consistent with previous reports describing a protective role for SMAD2 against fibrogenesis. 75 This report delineates the key role that Akt plays in mediating the pro-fibrotic changes that occur during kidney injury and describes how BMP-7 can up-regulate PTEN to prevent activation of Akt signaling. We highlight the potential of Akt inhibition as a therapeutic approach to preventing progression of renal disease. It will be interesting to investigate whether Akt inhibitors, developed as anti-cancer and anti-inflammatory therapeutics 76 may also be useful as anti-fibrotic agents.
Methods:
Unilateral ureteral obstruction (UUO):
UUO was performed on 8-10 week old C57BL/6, FVB mice and kidneys harvested at 8 days. 49 Animals were randomized into two groups (n=5 each) receiving vehicle (20mM histidine, 140mM NaCl, Roche) or 300µg/kg recombinant human BMP-7 (R&D systems) i.p. on days 0, 2, 4, and 6. One third of each contralateral and obstructed kidney was formalin fixed, one third methyl Carnoy's fixed, and one third divided for RNA and protein extraction. The animal study was performed in accordance with ethical guidelines of UCD AREC and under license from the Department of Health. 
